Sales Growth YoY (Last Twelve Months): Collegium Corp (COLL)

Brandmark of collegiumpharma.com (COLL)

Collegium Pharmaceutical specializes in chronic pain therapy, leveraging stable benefits from the patent protection of its formulas. The use of unique opioid abuse-deterrent technologies transforms its asset portfolio into a reliable profit generator. Business success relies on the sales of non-opioid agents and strict compliance with regulatory standards. The GURU.Markets terminal displays a chart of the TTM revenue growth YoY, where the value of the indicator is 7.80.

Collegium Pharmaceutical, Inc. (COLL) Sales Growth YoY (TTM): for the period 02/11/2024 - 11/18/2026

collegiumpharma.com - analytical breakdowns and key metrics (COLL)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Analysis of all company metrics:COLL - Collegium Pharmaceutical
Signature product of Collegium Pharmaceutical

Professional investors select resilient assets by analyzing long-term patterns while filtering out short-term market noise. The TTM revenue growth rate compared to the previous year measures the percentage change in sales over a rolling 12-month period, confirming the stability of cash flows for Collegium Pharmaceutical (COLL) due to the maturity of its analgesic product line and the high demand for chronic pain medications.